Dickinson Andrew D bought GILD
January 31, 2025 · Form 4 insider transaction
Dickinson Andrew D bought 44,160 shares of Gilead Sciences, Inc. at $65.38 per share, a transaction worth $2.89M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
44,160
Price
$65.38
Total value
$2.89M
InsiderDickinson Andrew D
Role—
CompanyGilead Sciences, Inc. (GILD)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 31, 2025
Filing dateFebruary 3, 2025
Shares owned after273,053
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.